Holen Sie sich die Stockscreener-App
13.54
0.59%
-0.075
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$13.62
Offen:
$13.61
24-Stunden-Volumen:
919.48K
Relative Volume:
0.31
Marktkapitalisierung:
$2.70B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$-413.00M
KGV:
-6.5435
EPS:
-2.07
Netto-Cashflow:
$365.00M
1W Leistung:
-1.17%
1M Leistung:
-2.24%
6M Leistung:
-13.15%
1J Leistung:
-49.27%
1-Tages-Spanne:
$13.51
$13.80
1-Wochen-Bereich:
$13.47
$14.01
52-Wochen-Spanne:
$12.16
$27.48
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Vergleichen Sie XRAY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
13.54 | 2.70B | 3.90B | -413.00M | 365.00M | -2.07 |
|
ISRG
Intuitive Surgical Inc
|
433.37 | 155.58B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
188.37 | 53.24B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
273.19 | 39.71B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
77.67 | 38.27B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
258.24 | 18.52B | 2.96B | 487.70M | 344.00M | 6.68 |
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | Herabstufung | Needham | Buy → Hold |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-23 | Herabstufung | Jefferies | Buy → Hold |
| 2025-01-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | Bestätigt | Needham | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
Treasury Yields: Is DENTSPLY SIRONA Inc stock influenced by commodity pricesJuly 2025 Trade Ideas & Risk Controlled Daily Trade Plans - خودرو بانک
Dynamic Technology Lab Private Ltd Invests $366,000 in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
1 Healthcare Stock Worth Your Attention and 2 We Brush Off - TradingView
Villanova Investment Management Co LLC Has $419,000 Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dental Giant DENTSPLY SIRONA Inc. (XRAY) Keeps Wellspect Unit Amid Strong Market Potential - Yahoo Finance
Market Review: Can DENTSPLY SIRONA Inc lead its sector in growthWeekly Profit Analysis & Weekly Stock Breakout Alerts - خودرو بانک
Bayforest Capital Ltd Increases Stock Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Aug Drivers: Will DENTSPLY SIRONA Inc benefit from seasonalityWeekly Trend Summary & Long-Term Growth Plans - خودرو بانک
Levels Update: Is DENTSPLY SIRONA Inc stock technically oversold2025 Price Targets & Scalable Portfolio Growth Methods - خودرو بانک
Henry Schein To Showcase Future-Forward Digital Solutions at DS World 2025 - Dentistry Today
IPO Launch: Whats the fair value of DENTSPLY SIRONA Inc stockBreakout Watch & Weekly Top Gainers Trade List - خودرو بانک
Retail Trends: Is DENTSPLY SIRONA Inc stock good for income investorsCEO Change & Risk Controlled Daily Trade Plans - خودرو بانک
Breakouts Watch: Can DENTSPLY SIRONA Inc. weather a recessionJuly 2025 Closing Moves & Detailed Earnings Play Strategies - خودرو بانک
Sciencast Management LP Sells 32,903 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona retains Wellspect Healthcare post alternatives - MSN
Advisors Asset Management Inc. Has $1.56 Million Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Benign Growth For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Underpins Its Share Price - 富途牛牛
What to expect from Dentsply Sirona’s world clinical education events starting this September in Mexico - Oral Health Group
Dentsply Sirona Maintains Cancellation for International Dental Show (IDS) Even for New Date in September 2021 - Oral Health Group
DENTSPLY SIRONA (XRAY) Retains Wellspect Business Citing Greater Value for Shareholders - Yahoo Finance
Focus Partners Advisor Solutions LLC Invests $375,000 in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dental Supply Co.'s $84M Price-Fixing Deal Gets Final OK - Law360
Cubist Systematic Strategies LLC Sells 214,292 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona Retains Wellspect Following Strategic Review - MSN
DENTSPLY SIRONA Inc. Completes the Evaluation of Strategic Alternatives for Its Wellspect Healthcare Business - MarketScreener
Global dental events spotlight: Implant Summit set for Sweden in 2026, IADR returns to Japan in 2029 - Oral Health Group
DENTSPLY SIRONA Inc. $XRAY Shares Purchased by AQR Capital Management LLC - MarketBeat
Edmond DE Rothschild Holding S.A. Increases Stake in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Transcript : DENTSPLY SIRONA Inc. Presents at Baird Global Healthcare Conference 2025, Sep-09-2025 01 - MarketScreener
Dentsply Sirona Retains Wellspect Healthcare After Review - The Globe and Mail
Removable Partial Denture Market Set for Experience Strong - openPR.com
Can Traders Expect Breakout From DENTSPLY SIRONA Inc. This Week2025 Macro Impact & Verified High Yield Trade Plans - beatles.ru
Dentsply Sirona at Morgan Stanley Conference: Strategic Shifts and Challenges - Investing.com Canada
Deadline to Claim Your Payout from the $84M Dentsply Sirona Settlement Is in 1 Month - TradingView
Dentsply to keep Wellspect biz after considering alternatives - MassDevice
Dentsply Sirona to Retain Wellspect Healthcare Unit After Strategic Review - MarketScreener
Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives - The Manila Times
Dentsply Sirona Retains Wellspect Healthcare Following Strategic Review of Alternatives - Quiver Quantitative
Dentsply Sirona Retains Wellspect Healthcare as a Portfolio - GlobeNewswire
$2B Market Opportunity: Dentsply Sirona Retains Fast-Growing Wellspect Healthcare After Strategic Review - Stock Titan
Global Dental Consumables Market Set to Transform with - openPR.com
3 Reasons to Avoid XRAY and 1 Stock to Buy Instead - Yahoo Finance
Russell Investments Group Ltd. Sells 644,790 Shares of DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Live market analysis of DENTSPLY SIRONA Inc.Sell Signal & Accurate Technical Buy Alerts - Newser
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.95%
0.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):